Core Viewpoint - AdvanSix Inc. (ASIX) is set to release its third-quarter 2024 results on November 1, with mixed performance in previous quarters and a significant negative earnings surprise trend [1][10]. Revenue Estimates - The Zacks Consensus Estimate for ASIX's sales in the upcoming quarter is 97.5 million, indicating a 13.2% rise year over year [4]. - Caprolactam sales are expected to reach 87.2 million, suggesting a 3% year-over-year rise [5]. - Chemical Intermediates sales are forecasted at $103.8 million, indicating a 24.3% increase year over year [5]. Factors Influencing ASIX Stock - AdvanSix benefits from a differentiated product portfolio and favorable demand and pricing, particularly in nylon and ammonium sulfate [6][8]. - The company has seen higher sales in nylon and ammonium sulfate due to favorable supply and demand dynamics in North America [8]. - Despite challenges in the building and construction market due to high interest rates, nylon demand remains strong in engineered plastics and packaging applications [7]. Earnings Prediction - The Earnings ESP for ASIX is currently at 0.00%, with a consensus estimate for earnings at 66 cents for the third quarter [11]. - The company holds a Zacks Rank of 3, indicating a hold position [11].
AdvanSix to Report Q3 Earnings: What's in the Cards for the Stock?